Shahrtash Seyed Abbas, Ghnim Zahraa Sabah, Ghaheri Mohammad, Adabi Javid, Hassanzadeh Mohammad Amir, Yasamineh Saman, Afkhami Hamed, Kheirkhah Amir Hossein, Gholizadeh Omid, Moghadam Hesam Zendehdel
Department of Pharmaceutical Engineering, University of Tehran, Tehran, Iran.
Department of Pharmacy, Al-Noor University College, Nineveh, Iraq.
Mol Biotechnol. 2025 Jan;67(1):54-79. doi: 10.1007/s12033-024-01052-6. Epub 2024 Feb 23.
Humans contract the Chikungunya virus (CHIKV), an alphavirus transmitted by mosquitoes that induces acute and chronic musculoskeletal discomfort and fever. Millions of cases of the disease have been attributed to CHIKV in the Indian Ocean region since 2004, and the virus has since spread to Europe, the Middle East, and the Pacific. The exponential proliferation of CHIKV in recent times underscores the critical nature of implementing preventative measures and exploring potential control strategies. The principal laboratory test employed to diagnose infection in serum samples collected over six days after the onset of symptoms is the detection of CHIKV or viral RNA. Although two commercially available real-time reverse transcription-polymerase chain reaction products exist, data on their validity are limited. A diagnostic instrument that is rapid, sensitive, specific, and cost-effective is, therefore an absolute necessity, particularly in developing nations. Biosensors have demonstrated considerable potential in the realm of pathogen detection. The rapid and sensitive detection of viruses has been facilitated by the development of numerous types of biosensors, including affinity-based nano-biosensors, graphene affinity-based biosensors, optical nano-biosensors, surface Plasmon Resonance-based optical nano-biosensors, and electrochemical nano-biosensors. Furthermore, the utilization of nanomaterials for signal extension, including but not limited to gold and silver nanoparticles, quantum dots, and iron oxide NPs, has enhanced the precision and sensitivity of biosensors. The developed innovative diagnostic method is time-efficient, precise, and economical; it can be implemented as a point-of-care device. The technique may be implemented in diagnostic laboratories and hospitals to identify patients infected with CHIKV. Throughout this article, we have examined a multitude of CHIKV nano-biosensors and their respective properties. Following a discussion of representative nanotechnologies for biosensors, numerous NPs-assisted CHIKV nano-biosensors are summarized in this article. As a result, we anticipate that this review will furnish a significant foundation for advancing innovative CHIKV nano-biosensors.
人类会感染基孔肯雅病毒(CHIKV),这是一种由蚊子传播的甲病毒,会引发急性和慢性肌肉骨骼不适以及发热症状。自2004年以来,印度洋地区数百万例该疾病病例都归因于基孔肯雅病毒,此后该病毒已传播到欧洲、中东和太平洋地区。近期基孔肯雅病毒的指数级扩散凸显了实施预防措施和探索潜在控制策略的紧迫性。用于诊断症状出现六天后采集的血清样本中感染情况的主要实验室检测方法是检测基孔肯雅病毒或病毒RNA。尽管有两种市售的实时逆转录 - 聚合酶链反应产品,但关于它们有效性的数据有限。因此,一种快速、灵敏、特异且经济高效的诊断仪器是绝对必要的,尤其是在发展中国家。生物传感器在病原体检测领域已展现出巨大潜力。包括基于亲和力的纳米生物传感器、基于石墨烯亲和力的生物传感器、光学纳米生物传感器、基于表面等离子体共振的光学纳米生物传感器以及电化学纳米生物传感器在内的多种类型生物传感器的发展,促进了病毒的快速灵敏检测。此外,利用纳米材料进行信号放大,包括但不限于金和银纳米颗粒、量子点和氧化铁纳米粒子,提高了生物传感器的精度和灵敏度。所开发的创新诊断方法省时、精确且经济;它可作为即时检测设备来实施。该技术可在诊断实验室和医院中用于识别感染基孔肯雅病毒的患者。在本文中,我们研究了多种基孔肯雅病毒纳米生物传感器及其各自特性。在讨论了生物传感器的代表性纳米技术之后,本文总结了众多纳米粒子辅助的基孔肯雅病毒纳米生物传感器。因此,我们预计这篇综述将为推进创新型基孔肯雅病毒纳米生物传感器提供重要基础。